Presentation Outline ICHP Annual Meeting September 13-15

Bortezomib-Thalidomide-Dexamethasone
Compared with Thalidomide-
Dexamethasone as Induction and
Consolidation Therapy Before and After
Double Autologous Transplantation In Newly
Diagnosed Multiple Myeloma: Results From a
Randomized Phase 3 Study
Michele Cavo, Giulia Perrone, Silvia Buttignol, Elisabetta Calabrese, Monica Galli,
Sara Bringhen, Tonino Spadano, Luca Baldini, Tommaso Caravita, Chiara Nozzoli,
Annamaria Brioli, Luciano Masini, Anna Furlan, Lucia Pantani, Daniele Derudas,
Stelvio Ballanti, Francesco Pisani, Valerio De Stefano, Gioacchino Catania, Luca
Castagna, Felicetto Ferrara, Vincenzo Callea, Pellegrino Musto, Elena Zamagni,
and Michele Baccarani
Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy;
Department of Hematology/Oncology, University of Bologna, Bologna, Italy; 3GIMEMA Italian
Myeloma Network, Italy
Cavo M, et al. Blood (ASH Annual Meeting Abstracts). 2010;116:42.
Increased CR-nCR Rates with
VTD Compared to TD
Percent
80
70
60
50
40
30
20
10
0
P